Solid pancreatic lesions not less than 10 mm Pancreas
Conditions
Interventions
Subjects will be randomly assigned to a conventional needle group or a new needle group for the needle used during EUS-FNB.
Conventional needle group: 22G Franseen needle (Acquire TM) will be used. Ne
Sponsors
Ishikawa Takuya
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)Patients with solid pancreatic lesions not less than 10 mm on CT or MRI which require histological diagnosis by EUS-FNB. (2)Patients over 20 years old at the time of enrollment. (3)Preservation of bone marrow function at the time of diagnosis. (4)Patients in which antithrombotic drugs are not used within one week or can be withdrawn or replaced. (5)Provision of written consent to participate in the study.
Exclusion criteria
Exclusion criteria: (1)Uncontrollable infection including active tuberculosis (2)Serious adverse events (3)Severe mental disorder (4)Judgement as being ineligible by the principal or subinvestigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Histological tissue collection rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Histological tissue collection rate among new needles Histological diagnostic ability Puncture success rate at first shot Evaluation of the easiness of the puncture Adverse events Comparison of core tissue length and area | — |
Contacts
Public ContactTakuya Ishikawa
Nagoya University Graduate School of Medicine
Outcome results
None listed